Biosergen AB's total assets for Q4 2024 were kr52.85M, an increase of 262.98% from the previous quarter. SE:BIOSGN total liabilities were kr3.71M for the fiscal quarter, a 29.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.